---
figid: PMC6858516__nihms-1054030-f0001
figtitle: Towards precision oncology in advanced prostate cancer
organisms:
- Homo sapiens
- Mus musculus
- NA
pmcid: PMC6858516
filename: nihms-1054030-f0001.jpg
figlink: /pmc/articles/PMC6858516/figure/F1/
number: F1
caption: Genomic alterations are often heterogeneous across patients with metastatic
  castration-resistant prostate cancer (mCRPC). Different alterations can have distinct
  biological roles in driving mCRPC progression and response, and resistance to therapies.
  By understanding each altered gene or pathway in an individual, precision medicine
  has the potential to guide unique therapeutic approaches for patients and improve
  clinical outcomes. A, androgen; AR, androgen receptor; ARm, mutant AR; ARV, AR splice
  variant; CDK, cyclin-dependent kinase; NEPC, neuroendocrine prostate cancer.
papertitle: Towards precision oncology in advanced prostate cancer.
reftext: Sheng-Yu Ku, et al. Nat Rev Urol. ;16(11):645-654.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9180719
figid_alias: PMC6858516__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC6858516__F1
ndex: 3f9d0531-df0f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6858516__nihms-1054030-f0001.html
  '@type': Dataset
  description: Genomic alterations are often heterogeneous across patients with metastatic
    castration-resistant prostate cancer (mCRPC). Different alterations can have distinct
    biological roles in driving mCRPC progression and response, and resistance to
    therapies. By understanding each altered gene or pathway in an individual, precision
    medicine has the potential to guide unique therapeutic approaches for patients
    and improve clinical outcomes. A, androgen; AR, androgen receptor; ARm, mutant
    AR; ARV, AR splice variant; CDK, cyclin-dependent kinase; NEPC, neuroendocrine
    prostate cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AR
  - AKR1A1
  - ARMC9
  - CHEK2
  - ATM
  - BRCA2
  - CDK12
  - CDK1
  - CDK2
  - AKT1
  - AKT2
  - AKT3
  - PUM3
  - PCSK1N
  - TSPAN33
  - RB1
  - RBM45
  - TP53
  - CDK6
  - CDK4
  - CCND1
  - CCND2
  - CCND3
  - WARS1
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - Ar
  - Chek2
  - Atm
  - Tpm1
  - Brca2
  - Cdk12
  - Akt1
  - pk
  - Pcsk1n
  - Tspan33
  - Rb1
  - Trp53
  - Cdk6
  - Cdk4
  - .na.character
  - Gabrg2
  - Abiraterone
  - enzalutamide
  - platinum
  - PEN
  - adenocarcinoma
---
